• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为“地塞米松治疗月经过多研究”开发一种贝叶斯反应自适应试验设计。

Development of a Bayesian response-adaptive trial design for the Dexamethasone for Excessive Menstruation study.

作者信息

Holm Hansen Christian, Warner Pamela, Parker Richard A, Walker Brian R, Critchley Hilary Od, Weir Christopher J

机构信息

1 MRC Tropical Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK.

2 Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.

出版信息

Stat Methods Med Res. 2017 Dec;26(6):2681-2699. doi: 10.1177/0962280215606155. Epub 2015 Sep 30.

DOI:10.1177/0962280215606155
PMID:26423728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5753844/
Abstract

It is often unclear what specific adaptive trial design features lead to an efficient design which is also feasible to implement. This article describes the preparatory simulation study for a Bayesian response-adaptive dose-finding trial design. Dexamethasone for Excessive Menstruation aims to assess the efficacy of Dexamethasone in reducing excessive menstrual bleeding and to determine the best dose for further study. To maximise learning about the dose response, patients receive placebo or an active dose with randomisation probabilities adapting based on evidence from patients already recruited. The dose-response relationship is estimated using a flexible Bayesian Normal Dynamic Linear Model. Several competing design options were considered including: number of doses, proportion assigned to placebo, adaptation criterion, and number and timing of adaptations. We performed a fractional factorial study using SAS software to simulate virtual trial data for candidate adaptive designs under a variety of scenarios and to invoke WinBUGS for Bayesian model estimation. We analysed the simulated trial results using Normal linear models to estimate the effects of each design feature on empirical type I error and statistical power. Our readily-implemented approach using widely available statistical software identified a final design which performed robustly across a range of potential trial scenarios.

摘要

通常不清楚具体哪些适应性试验设计特征会产生一个既高效又可行的设计方案。本文描述了一项针对贝叶斯反应适应性剂量探索试验设计的预备性模拟研究。“地塞米松治疗月经过多”旨在评估地塞米松在减少月经过多方面的疗效,并确定进一步研究的最佳剂量。为了最大程度地了解剂量反应,患者接受安慰剂或活性剂量,随机分配概率根据已招募患者的证据进行调整。使用灵活的贝叶斯正态动态线性模型估计剂量反应关系。考虑了几种相互竞争的设计选项,包括:剂量数量、分配给安慰剂的比例、适应性标准以及适应的次数和时间。我们使用SAS软件进行了析因试验研究,以模拟各种情况下候选适应性设计的虚拟试验数据,并调用WinBUGS进行贝叶斯模型估计。我们使用正态线性模型分析模拟试验结果,以估计每个设计特征对经验性I型错误和统计功效的影响。我们使用广泛可用的统计软件的易于实施的方法确定了一个最终设计,该设计在一系列潜在试验场景中表现稳健。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/2aac5ed9fbe6/10.1177_0962280215606155-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/5191e9bafa11/10.1177_0962280215606155-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/31cd267207c6/10.1177_0962280215606155-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/2a8797a261c3/10.1177_0962280215606155-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/95c599a8d361/10.1177_0962280215606155-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/e24bccd4817b/10.1177_0962280215606155-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/eec7a250652d/10.1177_0962280215606155-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/2aac5ed9fbe6/10.1177_0962280215606155-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/5191e9bafa11/10.1177_0962280215606155-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/31cd267207c6/10.1177_0962280215606155-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/2a8797a261c3/10.1177_0962280215606155-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/95c599a8d361/10.1177_0962280215606155-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/e24bccd4817b/10.1177_0962280215606155-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/eec7a250652d/10.1177_0962280215606155-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7062/5753844/2aac5ed9fbe6/10.1177_0962280215606155-fig7.jpg

相似文献

1
Development of a Bayesian response-adaptive trial design for the Dexamethasone for Excessive Menstruation study.为“地塞米松治疗月经过多研究”开发一种贝叶斯反应自适应试验设计。
Stat Methods Med Res. 2017 Dec;26(6):2681-2699. doi: 10.1177/0962280215606155. Epub 2015 Sep 30.
2
Low-dose dexamethasone as a treatment for women with heavy menstrual bleeding: protocol for response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM).低剂量地塞米松治疗月经过多女性:适应性随机安慰剂对照剂量探索平行组试验(DexFEM)方案
BMJ Open. 2015 Jan 14;5(1):e006837. doi: 10.1136/bmjopen-2014-006837.
3
Low dose dexamethasone as treatment for women with heavy menstrual bleeding: A response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM).低剂量地塞米松治疗月经过多妇女:一项适应性随机安慰剂对照剂量探索平行组试验(DexFEM)。
EBioMedicine. 2021 Jul;69:103434. doi: 10.1016/j.ebiom.2021.103434. Epub 2021 Jul 2.
4
Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.用于响应自适应随机设计的瓮模型:基于非自适应随机试验的模拟研究
J Biopharm Stat. 2018;28(6):1203-1215. doi: 10.1080/10543406.2018.1452024. Epub 2018 Mar 22.
5
A practical guide to pre-trial simulations for Bayesian adaptive trials using SAS and BUGS.使用SAS和BUGS进行贝叶斯适应性试验的审前模拟实用指南。
Pharm Stat. 2018 Nov;17(6):854-865. doi: 10.1002/pst.1897. Epub 2018 Sep 14.
6
Using Bayesian pre-trial simulations to optimize the design of adaptive clinical trials in childhood nephrotic syndrome.利用贝叶斯预试验模拟优化儿童肾病综合征适应性临床试验的设计。
Contemp Clin Trials. 2025 Jun;153:107918. doi: 10.1016/j.cct.2025.107918. Epub 2025 Apr 15.
7
An adaptive trial design to optimize dose-schedule regimes with delayed outcomes.一种优化具有延迟结局的剂量方案的自适应试验设计。
Biometrics. 2020 Mar;76(1):304-315. doi: 10.1111/biom.13116. Epub 2019 Sep 19.
8
A Bayesian response-adaptive dose-finding and comparative effectiveness trial.一项贝叶斯反应自适应剂量探索与比较疗效试验。
Clin Trials. 2021 Feb;18(1):61-70. doi: 10.1177/1740774520965173. Epub 2020 Nov 24.
9
Effects of sceptical priors on the performance of adaptive clinical trials with binary outcomes.怀疑先验对二分类结局适应性临床试验性能的影响。
Pharm Stat. 2024 Sep-Oct;23(5):728-741. doi: 10.1002/pst.2387. Epub 2024 Mar 29.
10
A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials.多剂量、随机、安慰剂对照的 I/II 期临床试验的贝叶斯自适应设计。
Contemp Clin Trials. 2012 Jul;33(4):739-48. doi: 10.1016/j.cct.2012.03.001. Epub 2012 Mar 9.

引用本文的文献

1
Low dose dexamethasone as treatment for women with heavy menstrual bleeding: A response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM).低剂量地塞米松治疗月经过多妇女:一项适应性随机安慰剂对照剂量探索平行组试验(DexFEM)。
EBioMedicine. 2021 Jul;69:103434. doi: 10.1016/j.ebiom.2021.103434. Epub 2021 Jul 2.
2
A practical guide to pre-trial simulations for Bayesian adaptive trials using SAS and BUGS.使用SAS和BUGS进行贝叶斯适应性试验的审前模拟实用指南。
Pharm Stat. 2018 Nov;17(6):854-865. doi: 10.1002/pst.1897. Epub 2018 Sep 14.

本文引用的文献

1
Low-dose dexamethasone as a treatment for women with heavy menstrual bleeding: protocol for response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM).低剂量地塞米松治疗月经过多女性:适应性随机安慰剂对照剂量探索平行组试验(DexFEM)方案
BMJ Open. 2015 Jan 14;5(1):e006837. doi: 10.1136/bmjopen-2014-006837.
2
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data.纳入早期结果数据的无缝II/III期试验的数据驱动治疗选择。
Pharm Stat. 2014 Jul-Aug;13(4):238-46. doi: 10.1002/pst.1619. Epub 2014 May 2.
3
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.
一种新的自适应设计策略提高了继发进展型多发性硬化症临床试验的效率。
Mult Scler. 2011 Jan;17(1):81-8. doi: 10.1177/1352458510382129. Epub 2010 Aug 26.
4
Commentary on 'Designs for dose-escalation trials with quantitative responses'.关于“具有定量反应的剂量递增试验设计”的评论
Stat Med. 2009 Dec 30;28(30):3754-8; discussion 3759-60. doi: 10.1002/sim.3735.
5
Designs for dose-escalation trials with quantitative responses.具有定量反应的剂量递增试验设计。
Stat Med. 2009 Dec 30;28(30):3721-38. doi: 10.1002/sim.3646.
6
Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial.将多臂多阶段方法应用于前列腺癌临床试验中的问题:英国医学研究理事会(MRC)的STAMPEDE试验
Trials. 2009 Jun 11;10:39. doi: 10.1186/1745-6215-10-39.
7
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.晚期卵巢癌新型铂类治疗方案的评估:妇科肿瘤协作组的一项III期试验
J Clin Oncol. 2009 Mar 20;27(9):1419-25. doi: 10.1200/JCO.2008.19.1684. Epub 2009 Feb 17.
8
Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation.11β-羟基类固醇脱氢酶-2介导的皮质醇失活可能通过减少重度月经中血小板反应蛋白-1来增强子宫内膜血管生成。
J Clin Endocrinol Metab. 2009 Apr;94(4):1443-50. doi: 10.1210/jc.2008-1879. Epub 2009 Jan 21.
9
Speeding up the evaluation of new agents in cancer.加快癌症新药物的评估。
J Natl Cancer Inst. 2008 Sep 3;100(17):1204-14. doi: 10.1093/jnci/djn267. Epub 2008 Aug 26.
10
Flexible design and efficient implementation of adaptive dose-finding studies.适应性剂量探索研究的灵活设计与高效实施
J Biopharm Stat. 2007;17(6):1033-50. doi: 10.1080/10543400701643947.